.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
.
1243 Used Today
254 Used Today
Discount $10 On Your First Purchases Of $40 Or More
110 Used Today
38 Used Today